CD19 CAR–T cells of defined CD4+:CD8+ composition in adult B cell ALL patients-Reference-Cited by-同舟云学术

CD19 CAR–T cells of defined CD4+:CD8+ composition in adult B cell ALL patients

Published:2016-04-25 Issue:6 Volume:126 Page:2123-2138
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Turtle Cameron J.,Hanafi Laïla-Aïcha,Berger Carolina,Gooley Theodore A.,Cherian Sindhu,Hudecek Michael,Sommermeyer Daniel,Melville Katherine,Pender Barbara,Budiarto Tanya M.,Robinson Emily,Steevens Natalia N.,Chaney Colette,Soma Lorinda,Chen Xueyan,Yeung Cecilia,Wood Brent,Li Daniel,Cao Jianhong,Heimfeld Shelly,Jensen Michael C.,Riddell Stanley R.,Maloney David G.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference30 articles.

1. Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias

2. T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial

3. Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia

4. Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia

5. B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor–transduced T cells

Cited by 1684 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements of engineered live oncolytic biotherapeutics (microbe/virus/cells): Preclinical research and clinical progress;Journal of Controlled Release;2024-11

2. BCL6 overexpression in CD4+ T cells induces Tfh-like transdifferentiation and enhances antitumor efficiency of CAR-T therapy in pancreatic cancer;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-10

3. PET Imaging in Chimeric Antigen Receptor T-Cell Trafficking;PET Clinics;2024-10

4. Exosome-based nanoparticles and cancer immunotherapy;Biomedicine & Pharmacotherapy;2024-10

5. Identification of early predictive biomarkers for severe cytokine release syndrome in pediatric patients with chimeric antigen receptor T-cell therapy;Frontiers in Immunology;2024-09-12